Nuveen Asset Management, LLC Bio Techne Corp Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 326,902 shares of TECH stock, worth $24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
326,902
Previous 474,162 31.06%
Holding current value
$24 Million
Previous $34 Million 23.11%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$70.96 - $82.35 $10.4 Million - $12.1 Million
-147,260 Reduced 31.06%
326,902 $26.1 Million
Q2 2024

Aug 09, 2024
BUY
$62.12 - $84.15 $5.79 Million - $7.84 Million
93,196 Added 24.46%
474,162 $34 Million
Q1 2024

May 13, 2024
BUY
$65.98 - $77.09 $323,104 - $377,509
4,897 Added 1.3%
380,966 $26.8 Million
Q4 2023

Feb 14, 2024
SELL
$52.83 - $78.22 $5.87 Million - $8.68 Million
-111,020 Reduced 22.79%
376,069 $29 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $66,439 - $87,989
-984 Reduced 0.2%
487,089 $33.2 Million
Q2 2023

Aug 14, 2023
SELL
$73.76 - $85.98 $655,210 - $763,760
-8,883 Reduced 1.79%
488,073 $39.8 Million
Q1 2023

May 15, 2023
BUY
$71.62 - $86.62 $6.63 Million - $8.02 Million
92,555 Added 22.89%
496,956 $36.9 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $24 Million - $105 Million
297,896 Added 279.7%
404,401 $33.5 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $893,956 - $1.24 Million
-3,164 Reduced 2.89%
106,505 $30.2 Million
Q2 2022

Aug 15, 2022
SELL
$322.67 - $449.65 $6.57 Million - $9.15 Million
-20,357 Reduced 15.66%
109,669 $38 Million
Q1 2022

May 16, 2022
BUY
$353.85 - $487.79 $10 Million - $13.8 Million
28,342 Added 27.87%
130,026 $57 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $1.78 Million - $2.05 Million
-3,898 Reduced 3.69%
101,684 $52.6 Million
Q3 2021

Nov 12, 2021
SELL
$444.87 - $538.88 $10.1 Million - $12.3 Million
-22,774 Reduced 17.74%
105,582 $51.2 Million
Q2 2021

Aug 16, 2021
SELL
$387.35 - $450.26 $6.68 Million - $7.76 Million
-17,233 Reduced 11.84%
128,356 $57.8 Million
Q1 2021

May 17, 2021
BUY
$314.62 - $411.0 $2.71 Million - $3.54 Million
8,609 Added 6.28%
145,589 $55.6 Million
Q4 2020

May 17, 2021
BUY
$246.9 - $321.87 $427,877 - $557,800
1,733 Added 1.28%
136,980 $43.5 Million
Q4 2020

Feb 16, 2021
BUY
$246.9 - $321.87 $11.6 Million - $15.1 Million
46,854 Added 53.01%
135,247 $42.9 Million
Q3 2020

Nov 16, 2020
SELL
$232.22 - $282.96 $753,321 - $917,922
-3,244 Reduced 3.54%
88,393 $21.9 Million
Q2 2020

Aug 14, 2020
BUY
$185.43 - $279.56 $689,985 - $1.04 Million
3,721 Added 4.23%
91,637 $24.2 Million
Q1 2020

May 14, 2020
SELL
$161.17 - $221.51 $3.25 Million - $4.47 Million
-20,185 Reduced 18.67%
87,916 $16.7 Million
Q4 2019

Feb 14, 2020
SELL
$189.68 - $222.09 $1.68 Million - $1.96 Million
-8,841 Reduced 7.56%
108,101 $23.7 Million
Q3 2019

Nov 14, 2019
SELL
$183.56 - $216.72 $1.68 Million - $1.98 Million
-9,149 Reduced 7.26%
116,942 $22.9 Million
Q2 2019

Aug 15, 2019
BUY
$188.72 - $215.43 $23.4 Million - $26.7 Million
124,128 Added 6323.38%
126,091 $26.3 Million
Q1 2019

May 14, 2019
BUY
$136.09 - $200.44 $267,144 - $393,463
1,963 New
1,963 $390,000
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $268,287 - $411,879
-2,021 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$144.9 - $165.58 $5,506 - $6,292
38 Added 1.92%
2,021 $299,000
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $225,248 - $245,455
1,983
1,983 $240,000

Others Institutions Holding TECH

# of Institutions
601
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.88B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email